Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Resisted Blood Flow Restriction

NCT: NCT07685119 · NOT_YET_RECRUITING

NCT IDNCT07685119
StatusNOT_YET_RECRUITING
Start Date2026-06-30
Completion2026-12-01
SponsorCairo University (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to investigate the effect of adding resisted blood flow restriction (BFR) training to a standard exercise program in adults aged 50-60 with Type 2 Diabetes Mellitus (T2DM). The main questions it aims to answer are: Does adding BFR training significantly increase muscle strength compared to standard exercise alone? Does the BFR intervention lead to measurable improvements in balance and physical function? Researchers will compare a group performing standard therapeutic exercise combined with BFR to a control group performing the same exercise program without BFR to see if the BFR group achieves superior gains in strength and functional independence. Participants will: Complete a 12-week supervised exercise program in an outpatient setting. Wear compression cuffs on their limbs during low-intensity resistance exercises (for the BFR group). Undergo assessments for muscle strength (via handheld dynamometry), balance, and functional mobility before and after the intervention.

Frequently Asked Questions

What is Effect of Resisted Blood Flow Restriction?

Effect of Resisted Blood Flow Restriction is a clinical trial registered under NCT07685119. Current status: NOT_YET_RECRUITING.

What is the status of NCT07685119?

The current status of NCT07685119 (Effect of Resisted Blood Flow Restriction) is: NOT_YET_RECRUITING.

When did Effect of Resisted Blood Flow Restriction start?

Effect of Resisted Blood Flow Restriction started on 2026-06-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.